QUOTE AND NEWS
newratings.com  Aug 19  Comment 
INDIANAPOLIS (dpa-AFX) - Eli Lilly and Co (LLY) said Monday the U.S. Food and Drug Administration granted tentative approval for Basaglar (insulin glargine injection), which is indicated to improve glycemic control in adults with type 2 diabetes...
StreetInsider.com  Aug 18  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/FDA+Awards+Tentative+Approval+for+Lilly%2C+Boehringer+Ingelheim%27s+Basaglar+%28LLY%29/9764028.html for the full story.
Jutia Group  Aug 18  Comment 
[PR Newswire] - Food and Drug Administration (FDA) today granted tentative approval for Basaglar™ (insulin glargine injection), which is indicated to improve glycemic control in adults with type 2 diabetes and in combination with mealtime...
SeekingAlpha  Aug 18  Comment 
By Balanced Investing: In the season of earnings release, Eli Lilly and Company (NYSE:LLY) has also joined the list by announcing its second quarter results. The company's performance can be assessed by analyzing the patents that it currently...
SeekingAlpha  Aug 14  Comment 
By Willow Street Investments: Introduction Recently, we wrote more detailed articles on Air Products and Chemicals (NYSE:APD) and Eli Lilly (NYSE:LLY). However, given the importance we believe substantial insider purchases should have, we are...
FierceBiotech  Aug 11  Comment 
Connecticut biotech Biodel is touting midstage results for its long-acting insulin, as the in-development BIOD-531 better controlled glucose than two Eli Lilly therapies.
SeekingAlpha  Aug 5  Comment 
By Northport Investments: Eli Lilly and Company (NYSE:LLY) is one of our favorite major American pharmaceutical investments. In recent years, there have been many headlines regarding the "patent cliffs" faced by the major pharmaceutical companies....
Jutia Group  Aug 4  Comment 
[PR Newswire] - RIDGEFIELD, Conn. and INDIANAPOLIS, Aug. 4, 2014 /PRNewswire/ -- The U.S. Prescribing Information for Jentadueto® (linagliptin and metformin hydrochloride) tablets now includes clinical trial data that showed linagliptin...
newratings.com  Aug 2  Comment 
INDIANAPOLIS (dpa-AFX) - Boehringer Ingelheim Pharmaceuticals, Inc. or BIPI and Eli Lilly and Co. (LLY) announced the U.S. Food and Drug Administration or FDA approved Jardiance tablets as an adjunct to diet and exercise to improve glycemic...




 

Very nice site!

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki